Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity

Saved in:
Bibliographic Details
Published in:Endocrinology, Diabetes & Metabolism Case Reports
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301675779227648
collection WordPress RSS
FRELIP Feed Integration
container_title Endocrinology, Diabetes & Metabolism Case Reports
description
discipline_display Endocrinology
discipline_facet Endocrinology
format Online Article
RSS Article
genre Journal Article
id rss_article:73771
institution FRELIP
journal_source_facet Endocrinology, Diabetes & Metabolism Case Reports
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
Endocrinology
General
Endocrinology
sub_discipline_display General
sub_discipline_facet General
subject_display Endocrinology
General
Endocrinology
Endocrinology
General
Endocrinology
subject_facet Endocrinology
General
Endocrinology
title Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
title_auth Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
title_full Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
title_fullStr Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
title_full_unstemmed Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
title_short Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
title_sort tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
topic Endocrinology
General
Endocrinology
url https://edm.bioscientifica.com/view/journals/edm/2026/2/EDM-26-0002.xml